Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression

Nianlan Yang, Weixi Zhang, Xing Ming Shi

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Cyclooxygenase-2 (COX-2) plays an important role in rheumatoid arthritis and therefore, has been a major target for anti-arthritis therapies. The expression of COX-2 is induced by inflammatory cytokines such as TNF-α and IL-1β, and inhibited by glucocorticoids. However, the molecular mechanisms underlying the anti-inflammatory and immune suppressive actions of glucocorticoids are not well defined. Here we report that glucocorticoid-induced leucine zipper (GILZ) mimics glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression in bone marrow mesenchymal stem cells, the cells that have been recently implicated in the pathogenesis and progression of rheumatoid arthritis. Usinga retrovirus-mediated gene expression approach we demonstrate that overexpression of GILZ inhibits TNF-α and IL-1β-induced COX-2 mRNA and protein expression, and knockdown of GILZ by shRNA reduces glucocorticoid inhibition of cytokine-induced COX-2 expression. Consistent to these results, overexpression of GILZ also inhibits NF-κB-mediated COX-2 promoter activity. Finally, we show that GILZ inhibits COX-2 expression by blocking NF-κB nuclear translocation. Our results suggest that GILZ is a key glucocorticoid effect mediator and that GILZ may have therapeutic value for novel anti-inflammation therapies.

Original languageEnglish (US)
Pages (from-to)1760-1771
Number of pages12
JournalJournal of Cellular Biochemistry
Volume103
Issue number6
DOIs
StatePublished - Apr 15 2008

Fingerprint

Leucine Zippers
Cyclooxygenase 2
Glucocorticoids
Cytokines
Interleukin-1
Rheumatoid Arthritis
Retroviridae
Stem cells
Mesenchymal Stromal Cells
Gene expression
Small Interfering RNA
Arthritis
Bone
Anti-Inflammatory Agents
Therapeutics

Keywords

  • Arthritis
  • COX-2
  • GILZ
  • Glucocorticoid
  • Mesenchymal stem cell

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. / Yang, Nianlan; Zhang, Weixi; Shi, Xing Ming.

In: Journal of Cellular Biochemistry, Vol. 103, No. 6, 15.04.2008, p. 1760-1771.

Research output: Contribution to journalArticle

@article{31b57fc95773440cb6176d028da0316b,
title = "Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression",
abstract = "Cyclooxygenase-2 (COX-2) plays an important role in rheumatoid arthritis and therefore, has been a major target for anti-arthritis therapies. The expression of COX-2 is induced by inflammatory cytokines such as TNF-α and IL-1β, and inhibited by glucocorticoids. However, the molecular mechanisms underlying the anti-inflammatory and immune suppressive actions of glucocorticoids are not well defined. Here we report that glucocorticoid-induced leucine zipper (GILZ) mimics glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression in bone marrow mesenchymal stem cells, the cells that have been recently implicated in the pathogenesis and progression of rheumatoid arthritis. Usinga retrovirus-mediated gene expression approach we demonstrate that overexpression of GILZ inhibits TNF-α and IL-1β-induced COX-2 mRNA and protein expression, and knockdown of GILZ by shRNA reduces glucocorticoid inhibition of cytokine-induced COX-2 expression. Consistent to these results, overexpression of GILZ also inhibits NF-κB-mediated COX-2 promoter activity. Finally, we show that GILZ inhibits COX-2 expression by blocking NF-κB nuclear translocation. Our results suggest that GILZ is a key glucocorticoid effect mediator and that GILZ may have therapeutic value for novel anti-inflammation therapies.",
keywords = "Arthritis, COX-2, GILZ, Glucocorticoid, Mesenchymal stem cell",
author = "Nianlan Yang and Weixi Zhang and Shi, {Xing Ming}",
year = "2008",
month = "4",
day = "15",
doi = "10.1002/jcb.21562",
language = "English (US)",
volume = "103",
pages = "1760--1771",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression

AU - Yang, Nianlan

AU - Zhang, Weixi

AU - Shi, Xing Ming

PY - 2008/4/15

Y1 - 2008/4/15

N2 - Cyclooxygenase-2 (COX-2) plays an important role in rheumatoid arthritis and therefore, has been a major target for anti-arthritis therapies. The expression of COX-2 is induced by inflammatory cytokines such as TNF-α and IL-1β, and inhibited by glucocorticoids. However, the molecular mechanisms underlying the anti-inflammatory and immune suppressive actions of glucocorticoids are not well defined. Here we report that glucocorticoid-induced leucine zipper (GILZ) mimics glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression in bone marrow mesenchymal stem cells, the cells that have been recently implicated in the pathogenesis and progression of rheumatoid arthritis. Usinga retrovirus-mediated gene expression approach we demonstrate that overexpression of GILZ inhibits TNF-α and IL-1β-induced COX-2 mRNA and protein expression, and knockdown of GILZ by shRNA reduces glucocorticoid inhibition of cytokine-induced COX-2 expression. Consistent to these results, overexpression of GILZ also inhibits NF-κB-mediated COX-2 promoter activity. Finally, we show that GILZ inhibits COX-2 expression by blocking NF-κB nuclear translocation. Our results suggest that GILZ is a key glucocorticoid effect mediator and that GILZ may have therapeutic value for novel anti-inflammation therapies.

AB - Cyclooxygenase-2 (COX-2) plays an important role in rheumatoid arthritis and therefore, has been a major target for anti-arthritis therapies. The expression of COX-2 is induced by inflammatory cytokines such as TNF-α and IL-1β, and inhibited by glucocorticoids. However, the molecular mechanisms underlying the anti-inflammatory and immune suppressive actions of glucocorticoids are not well defined. Here we report that glucocorticoid-induced leucine zipper (GILZ) mimics glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression in bone marrow mesenchymal stem cells, the cells that have been recently implicated in the pathogenesis and progression of rheumatoid arthritis. Usinga retrovirus-mediated gene expression approach we demonstrate that overexpression of GILZ inhibits TNF-α and IL-1β-induced COX-2 mRNA and protein expression, and knockdown of GILZ by shRNA reduces glucocorticoid inhibition of cytokine-induced COX-2 expression. Consistent to these results, overexpression of GILZ also inhibits NF-κB-mediated COX-2 promoter activity. Finally, we show that GILZ inhibits COX-2 expression by blocking NF-κB nuclear translocation. Our results suggest that GILZ is a key glucocorticoid effect mediator and that GILZ may have therapeutic value for novel anti-inflammation therapies.

KW - Arthritis

KW - COX-2

KW - GILZ

KW - Glucocorticoid

KW - Mesenchymal stem cell

UR - http://www.scopus.com/inward/record.url?scp=41849146079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41849146079&partnerID=8YFLogxK

U2 - 10.1002/jcb.21562

DO - 10.1002/jcb.21562

M3 - Article

C2 - 17910039

AN - SCOPUS:41849146079

VL - 103

SP - 1760

EP - 1771

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 6

ER -